Progesterone Isoforms and Endometrial Cancer

Abstract

Get full access to this article

View all access options for this article.

References

1. Jemal A , Murray T , Ward E , et al. Cancer Statistics 2005. CA CancerJ Clin 2005;55:10-30.

2. Silverberg E , Boring CC , Squires TS . Cancer Statistics 1990. CA CancerJ Clin 1990;40:9-26.

3. Hendrickson M , Ross J , Eifel P , et al. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982;61:93-108.

4. Creasman WT , Kohler MF , Odicino F , Maisonneuve P , Boyle P . Prognosis of papillary serous, clear cell and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol 2004;95:593-596.

5. Persson I , Adami HO , Bergkvist L , et al. Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progestogens: Results of a prospective study. BMJ 1989; 298:147-151.

6. Li X , O'Malley BW . Unfolding the action of progesterone receptors. J Biol Chem 2003;278:39261-39264.

7. Horwitz KB , Alexander PS . In situ photolinked nuclear progesterone receptors of human breast cancer cells: Subunit molecular weights after transformation and translocation. Endocrinology 1983;113:2195-2201.

8. Kastner P , Kurst A , Turcotte B , et al. Two distinct estrogenregulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBOJ 1990;9:1603-1614.

9. Giagrande P , Kimbrel E , Edwards D , McDonnell D . The opposing 6 transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 2000;20:3102-3115.

10.

10. Hovland AR , Powell RL , Takimoto GS , Jung L , Horowitz KB . An N-terminal inhibitory function, 1F, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem 1998;272:5455-5460.

11.

11. Giangrande PH , Poflio G , McDonnell DP . Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. Biol Chem 1997;32:889-900.

12.

12. Wen DX , Xu YF , Mais DE , Goldman ME , McDonnell DP . The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 1994;14:8356-8364.

13.

13. Vegeto E , Shahbaz MM , Wen DX , Goldman ME , O'Malley BW , McDonnell DP . Human progesterone receptor A form is a cell-and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 1993;7:1244-1255.

14.

14. Mulac-Jericevic B , Mulhnax RA , DeMayo FJ , LydonJP , Connelly OM . Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 2000;289:1751-1754.

15.

15. De Vivo I , Huggins GS , Hankinson SE , et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. PNAS 2002;99:12263-12268.

16.

16. Migliaccio A , Piccolo D , Castoria G , et al. Activation of the Src/p21/ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 1998;17:2008-2018.

17.

17. FujimotoJ , Ichigo S , Hirose R , Sagaguchi H , Tamaya T . Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers. J Steroid Biochem Mol Biol 1997;62:449-454.

18.

18. Kumar NS , Richer J , Owen G , Litman E , Horwitz KB , Leslie KK . Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: Implications for unopposed estrogen action. Cancer Res 1998; 58:1860-1865.

19.

19. Arnett-Mansfield RL , deFazio A , Wain GV , et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res 2001;61:4576-4582.

20.

20. Smid-Koopman E , Kiihne LCM , Hanekamp EE , et al. Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA and/or PR-B-expressing endometrial cancer cell lines. J Soc Gynecol Invest 2005;12:285-292.

21.

21. Hanekamp EE , Gielen SCJP , DeRuiter PE , et al. Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: Possible involvement of cadherins. J Soc Gynecol Invest 2005;12:278-284.

22.

22. Leblanc M , Poncelet C , Soriano D , et al. Alteration of CD44 and cadherin expression: Possible association with augmented aggressiveness and invasiveness of endometrial carcinoma. Virchow's Arch 2001;438:78-85.

23.

23. Hanekamp EE , Kiuhne EC , Smid-Koopman E , et al. Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancer. EurJ Cancer 2002;38(Suppl 6):S71-S72.

24.

24. Hanekamp EE , Gielen SC , Smid-Koopman E , et al. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer. Clin Cancer Res 2003; 9:4190-4199.

25.

25. Leslie KK , Stein M-P , Kumar NS , et al. Progesterone receptor isoform identification and subcellular localization in endometrial cancer. Gynecol Oncol 2005;96:32-41.